Type 2-driven Inflammation - Atopic Dermatitis, Asthma, and Hypereosinophilia - Successfully Treated with Dupilumab. Benzecry V, Pravettoni V, Segatto G, Marzano AV, et al. J Investig Allergol Clin Immunol 2020 Jul 30:0. doi: 10.18176/jiaci.0614.

Read + Share

Amedeo Smart

Independent Medical Education

Benzecry V, Pravettoni V, Segatto G, Marzano AV, et al. Type 2-driven Inflammation - Atopic Dermatitis, Asthma, and Hypereosinophilia - Successfully Treated with Dupilumab. J Investig Allergol Clin Immunol 2020 Jul 30:0. doi: 10.18176/jiaci.0614.
PMID: 32732182